sermorelin with tirzepatide + Tirzepatide: Safety & Efficacy Tirzepatide and Sermorelin Together: Safety

Written By: Anamika Koshti, PharmD Reviewed By: Pharmacally Editorial Team Eli Lilly and Company has announced positive topline results from two pivotal Phase 3 studies of retatrutide, its investigational once-weekly triple hormone receptor agonist that targets glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors

Inject one 0.5 mg dose once weekly on the same day each week

While the answers below are general guidelines, medication storage details may differ from pharmacy to pharmacy

In addition, it suppresses your appetite, so you are less likely to gain back the weight you lost